News Sofinnova raises $200m for digital medicine fund Life sciences venture capital company Sofinnova has doubled down on its strategy to expand into digital medicine, closing its first dedicated fund for the category with $2
News After rebuffing Biogen, Sage pairs off with Supernus Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face